Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection.

Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection.

Item

http://www.wikidata.org/entity/Q40185369

Q40185369

about

Highly elevated soluble Tim-3 levels correlate with increased hepatocellular carcinoma risk and poor survival of hepatocellular carcinoma patients in chronic hepatitis B virus infection.

P2860

Q54211996-4BAF6DF3-C88A-4A8B-B6A7-6D33B196CBF8

P2860

Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection.

Item

http://www.wikidata.org/entity/Q40185369

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Circulating soluble programmed ...... c hepatitis B virus infection.

@en

type

Item

label

Circulating soluble programmed ...... c hepatitis B virus infection.

@en

prefLabel

Circulating soluble programmed ...... c hepatitis B virus infection.

@en

P1476

Circulating soluble programmed ...... c hepatitis B virus infection.

@en

P2093

Chunyan Li

http://www.w3.org/2001/XMLSchema#string

Fang Li

http://www.w3.org/2001/XMLSchema#string

Jiao Sang

http://www.w3.org/2001/XMLSchema#string

Na Li

http://www.w3.org/2001/XMLSchema#string

Qunying Han

http://www.w3.org/2001/XMLSchema#string

Wenxuan Zhao

http://www.w3.org/2001/XMLSchema#string

Yi Lv

http://www.w3.org/2001/XMLSchema#string

Zhengwen Liu

http://www.w3.org/2001/XMLSchema#string

Zhihua Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance

Alternative splice variants of the human PD-1 gene

Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

The natural history of chronic HBV infection and geographical differences.

CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection.

Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma.

PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.

Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T cells during chronic infection.

P304

46020-46033

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.17546

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28545019

http://www.w3.org/2001/XMLSchema#string

P932

5542245

http://www.w3.org/2001/XMLSchema#string

Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection.

about

P2860

P2860

Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932